Nexalin Technology, Inc. (NXL)

Market Cap	10.56M
Revenue (ttm)	110,748
Net Income (ttm)	-4.65M
Shares Out	7.44M
EPS (ttm)	-0.63
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	72,601
Open	1.450
Previous Close	1.390
Day's Range	1.410 - 1.540
52-Week Range	0.253 - 3.400
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 8, 2024

About NXL

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medica...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Sep 16, 2022
• Employees: 6
• Stock Exchange: NASDAQ
• Ticker Symbol: NXL

Financial Performance

In 2023, NXL's revenue was $110,748, a decrease of -91.62% compared to the previous year's $1.32 million. Losses were -$4.65 million, 173.8% more than in 2022.